University research records

Institute of Post Graduate Medical Education and Research

8 imported, source-linked research records. Open-access records.

Open-access records

8 matching research records

Topic: Canagliflozin and SGLT2. Only records linked to Institute of Post Graduate Medical Education and Research are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.

Back to university profile →

Showing 1–8 of 8 matching records. Counts update as records arrive.

  1. Translating localized renal reprogramming to systemic protection: A comprehensive review of SGLT2 inhibitors in cardiovascular-kidney-metabolic syndrome

    September 1, 2026 · 0 citations · Open access

    Open original record →

  2. COMPARATIVE EFFICACY OF SODIUM–GLUCOSE COTRANSPORTER-2 INHIBITORS VERSUS PLACEBO ON CARDIOVASCULAR MORTALITY IN ADULTS WITH HEART FAILURE: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

    March 15, 2026 · 0 citations · Open access

    Open original record →

  3. Dapagliflozin induces corneal nerve regeneration in subjects with type 2 diabetes by altering the AGE/RAGE pathway

    December 1, 2025 · 0 citations · Open access

    Open original record →

  4. Effect of Sodium Glucose Transporter 2 Inhibitor (SGLT2i) on Peak Left Atrium Strain in Patients with Heart Failure with Preserved Ejection Fraction (HFpEF) and its Correlation with N - Terminal Pro B Type Natriuretic Peptide (NT pro BNP) Level : A Follow Up Study

    November 14, 2025 · 0 citations · Open access

    Open original record →

  5. SGLT2 inhibitors and cardiovascular outcomes in heart failure with mildly reduced and preserved ejection fraction: A systematic review and meta-analysis

    March 1, 2023 · 35 citations · Open access

    Open original record →

  6. SGLT2 Inhibitors in the Management of Chronic Kidney Disease: An Expert Consensus

    October 1, 2022 · 3 citations · Open access

    Open original record →

  7. Remogliflozin Etabonate in the Treatment of Type 2 Diabetes: Design, Development, and Place in Therapy

    June 1, 2020 · 53 citations · Open access

    Open original record →

  8. Role of metformin, Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) receptor agonists, and orlistat based multidrug therapy in glycemic control, weight loss, and euglycemia in diabesity: A real-world experience

    January 1, 2019 · 14 citations · Open access

    Open original record →